The Hospital to Home Study: A Pragmatic Trial to Optimize Transitions and Address Disparities in Asthma Care
从医院到家庭研究:优化过渡和解决哮喘护理差异的务实试验
基本信息
- 批准号:10583611
- 负责人:
- 金额:$ 90.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-01 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:Academic achievementAcuteAddressAdmission activityAdolescentAdultAffectAmericanAsthmaCOVID-19 pandemic effectsCaregiversCaringChildChild CareChild health equityChildhoodChildhood AsthmaChronic DiseaseClinicalCognitionCommunity HospitalsDedicationsDiseaseDisparityEmergency department visitFaceFeedbackGoalsGuidelinesHandHealthHomeHospitalizationHospitalized ChildHospitalsIndividualInfrastructureInpatientsInterventionInterviewMethodsMissionMorbidity - disease rateNational Heart, Lung, and Blood InstituteOutcomeParticipantPediatric HospitalsPediatric ResearchPharmaceutical PreparationsPreventionPreventive Health ServicesPublic HealthQuality of CareReduce health disparitiesResearchResourcesSchool Drop-OutsSchool-Age PopulationSchoolsSiteStudent DropoutsTestingUnited States National Institutes of HealthUpdateVariantWorkYouthacceptability and feasibilityagedasthma exacerbationchild servicesclinical practicecommunity engagementcomparison interventiondisorder controldisparity reductioneffectiveness/implementation trialevidence basefollow-upgroup interventionhealth care disparityhealth care service utilizationhealth disparityhealth equity promotionhealth outcome disparityhigh riskhigh risk populationhospital readmissionimplementation evaluationimplementation facilitatorsimplementation interventionimprovedimproved outcomeinnovationinsightinterdisciplinary approachmortalitymulti-component interventionnovelpatient orientedpilot trialpragmatic trialprematureprimary care providerprogramsprovider communicationracial disparityrandomized trialrecruitsocioeconomicsstandardize guidelinessuccessful interventiontelehealthtrial designtrial enrollmentusual care arm
项目摘要
Despite evidence-based NIH guidelines for asthma, overall morbidity among children has not significantly
decreased. In the US, asthma accounts for >150,000 hospitalizations, >600,000 emergency department visits,
and nearly 14 million missed school days annually. Striking socioeconomic and racial inequities persist with
under-resourced children incurring a disproportionate share of asthma morbidity. Our long-term goal is to
improve health outcomes and reduce disparities in asthma morbidity for all children. Our team will address
critical barriers to achieving broad-scale improvements in outcomes for all children hospitalized with asthma in
the US, in any setting. This proposal’s overall objective is to improve asthma outcomes by conducting a
patient-centered, multicomponent intervention focusing on under-resourced children with asthma at both
children’s (ChH) and community hospitals (CH). Intervention components are navigation support, medications
in-hand at discharge, primary care provider communication, school-based therapy, and home assessment.
Leveraging feedback from stakeholders and building on the telehealth infrastructure, we will utilize a pragmatic
effectiveness-implementation trial design to test the overall hypothesis that a refined version of the Hospital-to-
Home (H2H) intervention will reduce asthma readmissions over a 12-month follow-up period. The hypothesis
will be tested in the following aims. (1): Engage key stakeholders to identify barriers and facilitators for
implementation of the components of H2H at children’s (ChH) and community hospitals (CHs). We will conduct
qualitative interviews to identify barriers and facilitators and refine each component for optimal implementation.
(2): Evaluate health outcomes of the H2H intervention compared to usual care control group for children
hospitalized with an asthma exacerbation at ChH and CH sites. We propose a multi-center, randomized trial
enrolling 340 caregiver-child (aged 4-12yrs) dyads during hospitalization to a multi-component intervention. (3):
Evaluate implementation of each component of the H2H intervention and assess impact of implementation on
health outcomes. We will evaluate feasibility, acceptability, and fidelity using mixed-methods to assess
variation in implementation of each component across sites and their impact on health outcomes. By focusing
on broader implementation at both ChHs and CHs, this innovative proposal has significant implications for
improving asthma management and reducing health disparities incurred by under-resourced school-aged
children. This proposal is aligned with NIH’s mission to address health disparities and will provide crucial
insights in intervention implementation at all types of hospital settings that care for children. Because the
hospitalization for children with asthma serves a high-risk population who may otherwise be difficult to reach,
identifying the most clinically effective method by which to deliver a preventative health service is urgently
needed. This work has the potential to shift current hospitalization clinical practice paradigms from only acute
encounters for asthma exacerbations to the broader management of public health prevention.
尽管有基于证据的NIH哮喘指南,儿童的总体发病率并没有显著增加。
降低在美国,哮喘占> 150,000次住院,> 600,000次急诊,
每年有近1400万人缺课。惊人的社会经济和种族不平等持续存在,
资源不足的儿童在哮喘发病率中所占比例过高。我们的长期目标是
改善所有儿童的健康结果并减少哮喘发病率的差异。我们的团队将致力于
所有哮喘住院儿童结局实现大规模改善的关键障碍
美国在任何情况下该提案的总体目标是通过开展一项
以患者为中心的多成分干预,重点关注资源不足的哮喘儿童,
儿童医院(ChH)和社区医院(CH)。干预组件是导航支持、药物
在出院时,初级保健提供者沟通,学校为基础的治疗,和家庭评估。
利用利益相关者的反馈,并在远程医疗基础设施的基础上,我们将利用务实的
有效性实施试验设计,以检验总体假设,即医院到医院的改进版本,
家庭(H2 H)干预将在12个月的随访期内减少哮喘再入院。的假设
将在以下目标中进行测试。(1):让主要利益攸关方参与,以确定实现以下目标的障碍和促进因素:
在儿童医院和社区医院实施保健到健康的组成部分。我们会进行
定性访谈,以确定障碍和促进因素,并完善每个组成部分,以实现最佳实施。
(2):评估H2 H干预与常规护理对照组儿童的健康结果
在ChH和CH研究中心因哮喘急性发作住院。我们建议进行一项多中心随机试验
在住院期间招募了340名双胞胎儿童(4- 12岁)进行多组分干预。(3):
评价保健干预措施每个组成部分的执行情况,并评估执行工作对
健康成果。我们将使用混合方法评估可行性、可接受性和保真度,
各地点每个组成部分的执行情况及其对健康结果的影响存在差异。通过专注
关于在社区卫生服务和社区卫生服务中更广泛的实施,这一创新建议对以下方面具有重要意义:
改善哮喘管理,减少资源不足的学龄儿童的健康差距
孩子这项提案与NIH的使命一致,以解决健康差距,并将提供关键的
在所有类型的儿童护理医院实施干预措施的见解。因为
哮喘儿童的住院治疗服务于高风险人群,
确定最有效的临床方法,以提供预防性卫生服务,是迫切需要的,
needed.这项工作有可能改变目前的住院临床实践范式,从只有急性
从哮喘急性发作到更广泛的公共卫生预防管理。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kavita Parikh其他文献
Kavita Parikh的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kavita Parikh', 18)}}的其他基金
Detecting and Understanding Disparities in Pediatric Safety Events for Hospitalized Children
检测和了解住院儿童儿科安全事件的差异
- 批准号:
10661525 - 财政年份:2022
- 资助金额:
$ 90.7万 - 项目类别:
Detecting and Understanding Disparities in Pediatric Safety Events for Hospitalized Children
检测和了解住院儿童儿科安全事件的差异
- 批准号:
10450528 - 财政年份:2022
- 资助金额:
$ 90.7万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 90.7万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 90.7万 - 项目类别:
Operating Grants